University of Southern California

Immudx, Inc.

Zoltan A Tokes

Alan Rembaum

William E Shell

Michael H Burnam

Kathryn E Rogers

A method and means for determining the risk of future cardiac ischemic events in a patient after a sentinel event in that same patient, wherein levels of acid glycoprotein and CK-MB are monitored relative to predetermined threshold levels, within a prescribed time frame after the sentinel event, and these monitored levels are then correlated with the predicted likelihood of future cardiac ischemic events to classify such cardiac patients into categories of risk.

Method and means for assessment and prediction of risk of subsequent

Anthracycline cancer drugs are covalently coupled to polymeric particles having a diameter of greater than about 0.5 microns to produce pharmaceutical preparations having enhanced cytostatic activity. The coupling of drugs to polymeric carriers shows increased activity against cancer cells, allows the bound drug to retain its cytostatic activity after repeated uses and shows an increase in activity against drug resistant cells.

Growing community of inventors

Los Angeles, CA, United States of America

Zoltan A Tokes